Dalmane and Sinusitis - a phase IV clinical study of FDA data

Summary:

Sinusitis is reported as a side effect among people who take Dalmane (flurazepam hydrochloride), especially for people who are female, 40-49 old, also take Celexa, and have Hepatitis c.

The phase IV clinical study analyzes which people have Sinusitis when taking Dalmane. It is created by eHealthMe based on reports of 1,224 people who have side effects when taking Dalmane from the FDA, and is updated regularly.

What is Dalmane?

Dalmane has active ingredients of flurazepam hydrochloride. It is often used in insomnia. eHealthMe is studying from 1,269 Dalmane users. Check the latest studies of Dalmane.

What is Sinusitis?

Sinusitis (inflammation of sinus) is found to be associated with 2,386 drugs and 2,668 conditions by eHealthMe. Check the latest studies of Sinusitis.

On Jul, 31, 2025

1,224 people reported to have side effects when taking Dalmane.
Among them, 43 people (3.51%) have Sinusitis.

Among these 43 people:

What is the gender of people who have Sinusitis when taking Dalmane? *

female: 76.74 %
male: 23.26 %

What is the age of people who have Sinusitis when taking Dalmane? *

What are other drugs people take besides Dalmane? *

What are other side effects people have besides Sinusitis? *

Pain: 29 people, 67.44%
Depression: 28 people, 65.12%
Vision Blurred: 25 people, 58.14%
Dyspnea (difficult or laboured breathing): 24 people, 55.81%
Memory Loss: 24 people, 55.81%
Joint Pain: 24 people, 55.81%
Headache (pain in head): 24 people, 55.81%
Muscle Spasms (muscle contraction): 23 people, 53.49%
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets): 23 people, 53.49%
Fatigue (feeling of tiredness): 21 people, 48.84%

What are the existing conditions these people have? *

Hepatitis C: 16 people, 37.21%
Sleep Apnea Syndrome: 11 people, 25.58%
Pain: 9 people, 20.93%
High Blood Pressure: 7 people, 16.28%
Depression: 6 people, 13.95%
Hepatitis A: 5 people, 11.63%
Hepatitis B: 4 people, 9.30%
Bone Loss: 4 people, 9.30%
Bone Density Decreased: 4 people, 9.30%
Metastases To Bone (cancer spreads to bone): 3 people, 6.98%

* Approximation only. Some reports may have incomplete information.

Do you take Dalmane and have Sinusitis?

- Check whether Sinusitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Dalmane:

Dalmane (1,269 reports)

Sinusitis treatments and more:

Sinusitis (153,471 reports)

How severe was Sinusitis and when was it recovered:

Sinusitis in Dalmane

Browse all side effects of Dalmane:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Sinusitis:

Sinusitis (2,386 drugs)

Browse all the conditions that are associated with Sinusitis:

Sinusitis (2,668 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on flurazepam hydrochloride (the active ingredients of Dalmane) and Dalmane (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.